{"url_path":"/sec/grce/10-k/2026/item-14","section_key":"item-14","section_title":"Item 14 Principal Accountant Fees and Services","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-18","source_url":"https://www.sec.gov/Archives/edgar/data/1444192/0001140361-26-025662-index.html","accession_number":"0001140361-26-025662","cik":"0001444192","ticker":"GRCE","issuer_name":"Grace Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1444192/0001140361-26-025662-index.html","primary_entity_key":"0001444192","primary_entity_name":"Grace Therapeutics, Inc."},"word_count":66,"has_tables":true,"body_markdown":"Item 14.\n\nPrincipal Accountant Fees and Services\n\n \n\nThe information required by this Item will be set forth under the section entitled “Ratification of Appointment of Independent Registered Public Accounting Firm” in our 2026 Proxy Statement to be filed with the SEC within 120 days of March 31, 2026 and is incorporated by reference into this Annual Report on Form 10-K.\n\n \n\n70\n\n*Table of Contents*\n\nPART IV"}